CDRH Releases 2016 Priorities

By MedTech Intelligence Staff
No Comments

Leveraging big data and clinical evidence is top of mind.

Focusing on using big data and analytics to make regulatory and clinical decisions, CDRH has released its top priorities for next year. Released yesterday, “Regulatory Science Priorities (FY2016)”,  was compiled by the CDRH Center Science Council’s Regulatory Science Subcommittee (RSS).

The center defines regulatory science as “science in the service of regulation”. CDRH’s goal within this area is to improve the assessment of device safety, effectiveness, quality and performance.  Its priorities for fiscal year 2016 as outlined in the agency document are as follows:

  • Leverage “big data” for regulatory decision making
  • Leverage evidence from clinical experience and employ evidence synthesis across multiple domains in regulatory decision making
  • Improve the quality and effectiveness of reprocessing reusable medical devices
  • Develop computational modeling technologies to support regulatory decision making
  • Enhance performance of Digital Health and medical device cybersecurity
  • Incorporate human factors engineering principles into device design
  • Modernize biocompatibility / biological risk evaluation of device materials
  • Advance methods to predict clinical performance of medical devices and their materials
  • Advance the use of patient reported outcome measures (PROMS) in regulatory decision making
  • Collect and use patient experience/preference in regulatory decision making

Related Articles

  • Supplier Responsibility in Medical Device Recalls

    What is the responsibility of the design owner? What level of accountability does the supplier have? What follow-up actions must a supplier take? A variety of best practices need to be driven forward by both suppliers and OEMs in an…

  • Unannounced Audits

    Critical subcontractors and crucial suppliers will be subject to unannounced audits by notified bodies under the revised European device regulations. Richard DeRisio of TÜV Süd provides more details in this presentation.

  • Medical Device Supplier Certification: the Rx-360 Approach

    Rx-360, an international pharmaceutical supply chain consortium, which helps its members share best practices to ensure the integrity of the healthcare supply chain, is now gearing for growth in the device space. What lessons can device makers learn?

  • Trends to Watch For in Medical Device Industry

    Access to recently developed materials, new technological deliveries and access to new markets are only a few of the trends that have affected changes in the medical device market and industry.

Leave a Reply

Your email address will not be published. Required fields are marked *